Men with a GSTM1 deletion genotype, a GSTM1 and GSTT1 double deletion genotype, or a GSTT1 deletion gene and the GSTP1-A131 G polymorphism have an increased risk of developing prostate cancer [16]. This evidence concerns the gene GSTP1 and prostate carcinoma.